G01N 2333/8132
Plasminogen activator inhibitors
G01N2333/8132 (Plasminogen activator inhibitors) appears on 35 US grants and 43 published applications in this corpus.
Search patents in G01N- Granted patents
- 35
- Published applications
- 43
- Assignees
- 44
- Inventors
- 119
- Latest grant
- 21 Nov 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 4 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 3 |
| 2014 | 1 | 5 |
| 2015 | 1 | 1 |
| 2016 | 2 | 3 |
| 2017 | 0 | 1 |
| 2018 | 3 | 2 |
| 2019 | 0 | 3 |
| 2020 | 0 | 2 |
| 2021 | 3 | 0 |
| 2022 | 0 | 3 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biomarkers of vascular disease21 Nov 2023US 11,821,905 B2Arterez, Inc.
- System and method for determining risk of diabetes based on biochemical marker analysis2 Nov 2021US 11,162,955 B2Wallac Oy
- Biomarkers of vascular disease12 Oct 2021US 11,143,659 B2Arterez, Inc.
- Cell response assay for cancer and methods of producing and using same13 Apr 2021US 10,976,319 B2Siemens Healthcare Diagnostics Inc.
- System and method for determining risk of diabetes based on biochemical marker analysis6 Nov 2018US 10,119,978 B2Wallac Oy
- Use of biomarkers in treatment with bifidobacteria26 Mar 2026US 2026/0085364 A1International N&H Denmark Aps
- Bladder cancer biomarkers and methods of use2 Oct 2025US 2025/0305057 A1Nonagen Bioscience Corporation
- Methods and uses of inflammatory bowel disease biomarkers8 May 2025US 2025/0146075 A1Washington University
- Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation16 Nov 2023US 2023/0364089 A1Cereno Scientific AB
- Methods and uses of inflammatory bowel disease biomarkers5 Oct 2023US 2023/0313305 A1Washington University
Most cited
By later US patents
- Method of performing tissue plasminogen activator assay30US 5,175,087 ABiopool International, Inc. · 1992
- Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators16US 4,791,068 AScripps Clinic and Research Foundation · 1988
- Gene encoding an inhibitor of tissue-type and urokinase-type plasminogen activators14US 4,952,512 A1990
- Method for the determination of the activity of serine proteases or serine protease inhibitors14US 5,057,414 ABehringwerke Aktiengesellschaft · 1991
- Diagnosis of pre-eclampsia7US 7,425,419 B2King's College London · 2008